Willow Biosciences Inc (TSE:WLLW) has released an update.
Willow Biosciences Inc. reported a significant increase in revenue, reaching $1.0 million for the second quarter of 2024, a 600% jump from the previous year, and anticipates over $4 million in revenue for the year. The company has entered a lucrative partnership with Laurus Labs to develop biobased processes for pharmaceutical ingredients and has strengthened its financial position through a successful private placement and strategic corporate appointments.
For further insights into TSE:WLLW stock, check out TipRanks’ Stock Analysis page.
